(2S,3S,4S,5S,6R)-4,5-Dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate

Catalog No. :
ACQVSY853
CAS No. :
2165969-58-2
Molecular Formula :
C7H14O7S
Molecular Weight :
242.25

IUPAC Name:(2S,3S,4S,5S,6R)-4,5-dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate

(2S,3S,4S,5S,6R)-4,5-Dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$61.00Login to see priceIn stockInquiry
100g97%$193.00Login to see priceIn stockInquiry
500g97%$771.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3S,4S,5S,6R)-4,5-Dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate
IUPAC Name(2S,3S,4S,5S,6R)-4,5-dihydroxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate
Molecular FormulaC7H14O7S
Molecular Weight242.25
SMILESC[C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)C)OS(=O)(=O)O)O)O
InChI KeyNLMDZXKCTWKRSQ-IBISWUOJSA-N
Synonym[(2S,3S,4S,5S,6R)-4,5-dihydroxy-2,6-dimethyloxan-3-yl] hydrogen sulate;[(2S,3S,4S,5S,6R)-4,5-Dihydroxy-2,6-dimethyloxan-3-yl] hydrogen sulfate;Antiviral agent 51;Sulfated L-fucan
CAS No.2165969-58-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQVSY853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQVSY853 route product structure diagram
    ACQVSY8532165969-58-2 In Stock
Inquiry

2. ACQVSY853 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVSY853 route product structure diagram
    ACQVSY8532165969-58-2 In Stock
Inquiry

Comments (0)